Nathalie Adda

2019

In 2019, Nathalie Adda earned a total compensation of $1.6M as Senior Vice President, Chief Medical Officer at Enanta Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$164,133
Option Awards$890,470
Salary$436,725
Stock Awards$104,324
Other$19,151
Total$1,614,803

Adda received $890.5K in option awards, accounting for 55% of the total pay in 2019.

Adda also received $164.1K in non-equity incentive plan, $436.7K in salary, $104.3K in stock awards and $19.2K in other compensation.

Rankings

In 2019, Nathalie Adda's compensation ranked 6,963rd out of 13,971 executives tracked by ExecPay. In other words, Adda earned more than 50.2% of executives.

ClassificationRankingPercentile
All
6,963
out of 13,971
50th
Division
Manufacturing
2,662
out of 5,692
53rd
Major group
Chemicals And Allied Products
972
out of 2,189
56th
Industry group
Drugs
822
out of 1,875
56th
Industry
Pharmaceutical Preparations
603
out of 1,387
57th

Pay ratio

Nathalie Adda's Pay$1,614,803
Median Employee's Pay$260,099
Pay Ratio

6

to 1

In 2019, the annual total compensation of Nathalie Adda was $1,614,803.

The annual total compensation of the median employee at Enanta Pharmaceuticals was $260,099.

The ratio of Nathalie Adda's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on January 17, 2020.

Adda's colleagues

We found four more compensation records of executives who worked with Nathalie Adda at Enanta Pharmaceuticals in 2019.

2019

Jay Luly

Enanta Pharmaceuticals

Chief Executive Officer

2019

Yat Or

Enanta Pharmaceuticals

Chief Scientific Officer

2019

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

2019

Nathaniel Gardiner

Enanta Pharmaceuticals

General Counsel

News

In-depth

You may also like